LY3549492
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 12
Of
12
Go to page
1
April 22, 2025
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
(clinicaltrials.gov)
- P2 | N=275 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting
Enrollment closed • Genetic Disorders • Obesity
March 11, 2025
A Study of LY3549492 in Japanese Participants with Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
December 13, 2024
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
(clinicaltrials.gov)
- P2 | N=275 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
December 04, 2024
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
(clinicaltrials.gov)
- P2 | N=1040 | Recruiting | Sponsor: Eli Lilly and Company | N=765 ➔ 1040
Enrollment change • Genetic Disorders • Obesity
November 12, 2024
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
(clinicaltrials.gov)
- P2 | N=275 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Genetic Disorders • Obesity
May 30, 2024
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=80 | Completed | Sponsor: Eli Lilly and Company | Active, not recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
March 28, 2024
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: Eli Lilly and Company | Recruiting ➔ Completed
Trial completion
January 31, 2024
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=96 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting
Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
January 08, 2024
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: Eli Lilly and Company
New P1 trial
April 13, 2023
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=96 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Mar 2023 ➔ Mar 2024 | Trial primary completion date: Mar 2023 ➔ Mar 2024
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
May 26, 2022
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=96 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
April 14, 2022
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=96 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 12
Of
12
Go to page
1